Warhound secures 200 million dollars to breed genetically modified military dogs equipped with high-tech gear

Biotech entrepreneur Ben Lamm of Colossal Biosciences and Anduril founder Palmer Luckey have partnered to launch Warhound, a defense startup valued at $1.2 billion following a $200 million funding round. The investment includes backing from Sequoia, 8VC, and CIA-affiliated In-Q-Tel. Former Palantir executive David Spirk leads the venture as chief executive. [2][3][4]

Warhound is harvesting cells from top Belgian Malinois, German Shepherds, and Labradors to clone animals with edited genes designed to resist common ailments like hip dysplasia and cancer. Future versions may feature heightened senses and increased speed. Meanwhile, Anduril will supply hardware and software, equipping the dogs with sensor-laden ballistic vests and goggles to improve communication with human handlers. Warhound expects its first cloned litters to arrive in early 2027. [2][3]

The company plans to sell the animals to police forces, first responders, and the Pentagon. Warhound argues the project will resolve domestic shortages, claiming that over 80 percent of American military working dogs currently originate in Europe and that fewer than half prove fit for duty. While Colossal holds equity and licenses its cloning technology, Luckey is participating solely as a business partner. [2][3]